Skip to main content
Razan H Kharraz on Muck Rack

Razan H Kharraz

As seen in: Dove Medical Press, Respiratory Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Razan H

Contact Razan H, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor on Health-Related Quality of Life in Adults with Cystic Fibrosis: A 12-Month Multicenter Cohort Study

|
By Elizabeth Tullis, Jenna Sykes, Julian S. Tam, Razan H Kharraz, Xiayi Ma, Akshdeep Sandhu, Allison Love, Felix Ratjen, Jonathan H Rayment, Bradley S Quon, Anne L. Stephenson, Zosia Gryz, Yonatan Shulman
| Respiratory Medicine Verified
Keywords Cystic fibrosis adults health related quality of life elexacaftor/tezacaftor/ivacaftor Get full text access Log in, subscribe or purchase for full access. References: 1. Nichols, D.P. ∙ Paynter, A.C. ∙ Heltshe, S.L. ... Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: a clinical trial Am J Respir Crit Care Med. 2022; 205(5):529-539 2. Middleton, P.G. ∙ Mall, M.A. ∙ Dřevínek, P. ...
Open in Who Shared Issue with article?

The Impact of Biological Therapies and the Significance of Their Adher

|
By Riyad Al-Lehebi, Razan H Kharraz, Ohud Fahad Alreshidi
| Dove Medical Press
Introduction Asthma affects an estimated two million individuals in Saudi Arabia, with the majority experiencing uncontrolled symptoms.1 Severe asthma, a particularly concerning subset, impacts approximately 5–10% of asthmatics.
Open in Who Shared Issue with article?
See all 2 articles